TRIBUTE PHARMACEUTICALS CANADA INC.;PETER R. RIEHL;SUNGTACK SAMUEL HAHN
发明人:
PETER R. RIEHL,SUNGTACK SAMUEL HAHN
申请号：
IL17030905
公开号：
IL170309A
申请日:
2005.08.16
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400mg/20mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particularly in patients with severe and otherwise recalcitrant cystitis.
